Smartmatic sued Newsmax for defamation over false claims related to the 2020 presidential election. The trial was supposed to ...

Israeli Prime Minister Benjamin Netanyahu is heading to the UN as the various sides consider the U.S.-French ceasefire proposal for Israel and Hezbollah.

The founder of a notorious Chicago street gang is set to make his first appearance in court in more than 20 years. Larry Hoover hopes a new judge will undo a life sentence he received in 1998.

A new study finds that more than 90 million acres of wetlands — nearly all that exist in the Lower 48 U.S. states — may have lost federal protections after the Supreme Court’s recent ruling.

The U.S. government has disrupted Russian influence operations targeting U.S. voters. And it says Iran is behind attempts to ...

President Biden welcomes Ukraine’s President Zelenskyy with a pledge of additional military assistance. Zelenskyy also met with Vice President Harris and bipartisan groups in the House and Senate.

With Israel and Hezbollah locked in the fiercest fighting in decades, many Lebanese have taken refuge in schools, hotels and ...

NPR's Leila Fadel talks to Ayman Safadi, Jordan's deputy prime minister and foreign affairs minister, about the risk of an ...

NPR's Ailsa Chang speaks with New York State Sen. John Liu about New York City Mayor Eric Adams being indicted on five federal charges Thursday.

Nail art is going three dimensional. Customers now want texture, along with colorful designs. We went to see what customers are getting at the nail salon.

The FDA has approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage over current treatments is milder side effects.

The Food and Drug Administration is expected to approve KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.